Fairvalue-Calculator Fairvalue-Calculator
EN DE

InnoCan Pharma Corporation (INNPF) Fair Value & Analysis

Consumer Defensive · US · Market cap $10.8M

Price$2.10
Fair Value$2.50
Upside+19.0%
Quality80/100
Evidence: Low Range $2.08 – $2.91

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

InnoCan Pharma Corporation (INNPF) currently trades at $2.10, while our model-based Fair Value estimate is $2.50 — implying the stock looks roughly 19.0% undervalued today. We read business quality at 80/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

InnoCan Pharma Corporation operates as a pharmaceutical technology company in United States, Canada, Europe, and internationally. The company operates through two segments, Online sales and Other Operations. The company develops a cannabidiol (CBD)-loaded liposome drug delivery platform (CBD-LPT), which is in the preclinical trial phase to treat chronic pain management for human and veterinary health sectors. It also offers a pain-relieving topical composition, as well as compositions for the treatment of hemorrhoid, psoriasis of the scalp, vaginal atrophy, and diabetic symptoms. The company is also involved in development, manufacture, and marketing of cosmetic products. InnoCan Pharma Corporation was founded in 2017 and is headquartered in Calgary, Canada.

Open the full interactive analysis →

Similar stocks

The Procter & Gamble Company (PG) -45% L'Oréal S.A (LRLCF) -36% Unilever PLC (UNLYF) -22% Colgate-Palmolive Company (CPA) -30% Hindustan Unilever Limited (HINDUNILVR) -63% Reckitt Benckiser Group (RBGLY) +41%

Frequently asked questions

Is InnoCan Pharma Corporation (INNPF) undervalued?
As of Jun 25, 2026, our model estimates a fair value of $2.50 versus a price of $2.10 — about +19% (undervalued). Model-based estimate, not financial advice.
What is the fair value of INNPF?
Our 21-model fair value for InnoCan Pharma Corporation is $2.50 (as of Jun 25, 2026), built from audited fundamentals. The current price is $2.10.
What is the quality score of INNPF?
InnoCan Pharma Corporation has a Quality Score of 80/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.